science wire



Results 251 - 300 of 2606.

Health - Pharmacology - 03.05.2021
New findings on rare side effects after Corona vaccination
The latest research on the SARS-CoV-2 virus and its consequences. As of Monday, 17 May, visits by relatives are possible again under certain conditions.

Health - Pharmacology - 28.04.2021
Breaking down barriers to care for metastatic breast cancer patients
UCLA team recommends state-level policy changes to improve health insurance coverage, participation in clinical trials and access to palliative care UCLA team recommends state-level policy changes to

Pharmacology - Health - 28.04.2021
Preference for AZ vaccine declines - but vaccine confidence undented
The public's preference for the AstraZeneca Covid vaccine has declined since last month, and belief that it causes blood clots has increased - but despite this, vaccine confidence is higher than it w

Pharmacology - Health - 27.04.2021
ANTICOV: Largest Clinical Trial in Africa to Test New Drug Combination
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.

Pharmacology - Economics / Business - 25.04.2021

Health - Pharmacology - 23.04.2021
Drug that enables healing without scarring
Researchers have identified the mechanisms of scar formation in skin and demonstrated in mice a way to make wounds heal with normal skin instead of scar tissue. A simple question from a mentor - Why do we scar after an injury or surgical incision? - set  Michael Longaker , MD, on a 34-year quest for an answer.

Health - Pharmacology - 21.04.2021

Pharmacology - Health - 20.04.2021
Clamp technology promising for future vaccine development
University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective. The vaccine candidate developed by the team last year did not progress through to Phase 2/3 clinical trials, due to cross reactivity caused by the protein fragment used to stabilise the clamp design.

Pharmacology - Social Sciences - 19.04.2021
Researchers win £1.3M funding to make a portable device to detect street drug ’spice’
A portable device to detect spice is being developed at Bath. This will be the first gadget to give on-the-spot readings for the street drug.

Health - Pharmacology - 16.04.2021

Health - Pharmacology - 14.04.2021
Over-80s show similar antibody responses following single vaccination with either Pfizer or AstraZeneca vaccine - but cellular responses are enhanced after AstraZeneca vaccine
People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.

Health - Pharmacology - 14.04.2021
Profile: How UK doctor linked rare blood-clotting to AstraZeneca Covid jab
Professor Marie Scully (UCL Cardiovascular Science) is interviewed about her about her work identifying a new rare blood clotting syndrome linked to the AstraZeneca Covid-19 vaccine & established the correct test & treatments for patients, helping save lives.

Health - Pharmacology - 13.04.2021
COVID-19 drug screening hub at the University of Glasgow begins work
A new COVID-19 drug screening and resistance hub in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR), has begun its vital work.

Pharmacology - Health - 13.04.2021

Health - Pharmacology - 13.04.2021
Newly launched British biotech company pioneers ground-breaking potential treatments for COVID-19
Newly launched British biotech company pioneers ground-breaking potential treatments for COVID-19
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for coronavirus.

Health - Pharmacology - 13.04.2021
Artificial Intelligence used to automate assessment of Mesothelioma
Patients receiving treatment for the "asbestos cancer", Mesothelioma, are being assessed with Artificial Intelligence (AI) as part of a prototype imaging system which could revolutionise the way people with the disease are cared for.

Health - Pharmacology - 12.04.2021
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1,779 participants.

Health - Pharmacology - 12.04.2021
Weather forecasts that predict meningitis outbreaks
Weather forecasts that predict meningitis outbreaks
Scientists are using weather forecasts to predict the location and scale of impending meningitis outbreaks in sub-Saharan Africa. It is part of an early-warning system being piloted with the aim of giving health agencies more time to activate emergency response plans.

Pharmacology - 09.04.2021

Health - Pharmacology - 07.04.2021
Opinion: The risks of the AstraZeneca jab are so small, yet the gains are so great
Research into the potential link between the AstraZeneca Covid-19 vaccine and blood clots is urgently needed, but the benefits of the vaccine far outweigh the risks even if a causal link is established, says Professor David Werring (UCL Queen Square Institute of Neurology).

Health - Pharmacology - 02.04.2021
Cost-effective and life-saving treatment for nation’s opioid disorder epidemic
A Stanford team of decision scientists with colleagues at the VA Palo Alto Health Care System developed a mathematical model to assess the cost-effectiveness of various interventions to treat opioid use disorder.

Health - Pharmacology - 02.04.2021
Experimental Therapy for Parasitic Heart Disease May Also Help Stop COVID-19
By blocking human enzyme cathepsin L, chemical inhibitor K777 reduces coronavirus' ability to infect cell lines; clinical trials are underway James McKerrow, MD, PhD, dean of the Skaggs School of Pha

Health - Pharmacology - 01.04.2021
Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response. The research involved 100 people aged 80 to 96, who were living independently, and had received the Pfizer vaccine twice at three weeks apart.

Health - Pharmacology - 01.04.2021
How Well do COVID-19 Vaccines Work Over the Longer Term?
A clinical trial of college students, including those at UC San Diego, will try to answer that question, and whether vaccinated persons might still pose an infection risk to others COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death.

Health - Pharmacology - 31.03.2021
Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick d

Pharmacology - Health - 30.03.2021
Overwhelming public support for donating vaccines to low-income countries
A survey led by the University of Oxford has found that most people in high-income countries support donating some of their country's COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.

Health - Pharmacology - 30.03.2021
UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR

Health - Pharmacology - 30.03.2021
New therapeutic approach for bile duct cancer
New therapeutic approach for bile duct cancer
MHH research team investigates molecular biomarkers for individualised tumour therapy. Status: 30 March 2021 Intrahepatic cholangiocarcinoma (ICC) develops within the liver. With one to two cases per 100,000 inhabitants in Germany, ICC is one of the rare diseases overall, but it is the second most common liver cancer.

Career - Pharmacology - 30.03.2021
Uncertainty on cuts to research funding risks jeopardising UK’s position as a scientific superpower
Professor David Price, UCL Vice-Provost (Research), comments on recent uncertainty about, and cuts to, research funding: "From the rapid generation of vaccines by UK scientists to the discovery of ne